CANCER IS DETECTED TOO LATE
Exact Sciences is changing the way we think about detecting and treating cancer. As a leader in cancer testing, we are committed to providing earlier answers and life-changing treatment guidance.
INTRODUCING
Exact Sciences' new ultra-comprehensive genomic profiling test for
advanced cancers interrogates both DNA+RNA, revealing variants that
DNA alone may miss.
It uncovers rare or overlooked fusion genes and transcription variants
in nearly 20K genes and detects 41% of fusions at the RNA level alone*.
Results are delivered in an easy-to-interpret report with a spotlight on
insights that matter most.
* Retrospective analysis of 1509 clinical reports, of which 1261 included both DNA and RNA profiling. OncoExTra RNA findings detected variants in 5.9% [75/1261] of samples vs 3.5% [44/1261] in DNA analysis.
SUPPORTING PATIENTS
AT EVERY STEP
Exact Sciences’ current portfolio of products primarily focuses on colorectal, breast and prostate cancers, with research and development looking at the top 15 deadliest cancers, including multi-cancer testing.
Our vision is to eradicate cancer and the suffering it causes through tests that detect it earlier and provide guidance for successful treatment.
Screening
Prognosis/ Therapy Selection
Minimal Residual Disease
Recurrence Monitoring
Therapy Selection
EARLIER CANCER DETECTION STARTS HERE
At Exact Sciences, we are cancer fighters. We are united by our mission to change lives by providing earlier, smarter answers. Through advances in cancer detection and treatment guidance, we will help eradicate the disease and the suffering it causes.
RIGOROUS SCIENCE.
REVOLUTIONARY SOLUTIONS.
Our teams use their scientific expertise to continuously innovate.
WORLD-CLASS SERVICE FOR
PHYSICIANS AND PATIENTS
Exact Sciences Laboratories are dedicated to delivering the most accurate test results to support informed decision making.